Cellibre specializes in sustainable biomanufacturing and Symrise has made a strategic equity investment in the U.S.-based biotechnology company. With this move, Symrise will gain access to proprietary, fermentation-based technology which will assist in scalable production of high-value ingredients across food, beverage, cosmetics, and nutraceutical sectors.
Read on